SFDA CEO Meets EU Health and Food Safety Director-General

The Saudi Food and Drug Authority (SFDA) CEO Dr. Hisham Aljadhey met with the European Commission’s Director-General for Health and Food Safety Sandra Gallina in Brussels on February 20, 2025. The high-level meeting, attended by Saudi Ambassador to the European Union Haifa Al-Jedea, focused on enhancing international cooperation, harmonizing regulatory policies, and facilitating trade in food and pharmaceuticals between Saudi Arabia and the European Union.

Context and Background

The meeting underscores Saudi Arabia’s commitment to strengthening its global partnerships in health, food safety, and biotechnology. The SFDA has been actively working to align Saudi Arabia’s regulatory frameworks with international standards, ensuring the safety and quality of food and pharmaceutical products. This collaboration with the European Union marks a significant step in advancing Saudi Arabia’s position as a leader in these sectors.

Key Details

During the meeting, Dr. Aljadhey and Ms. Gallina reviewed the SFDA’s efforts to develop international food standards based on the highest global benchmarks. They also explored ways to streamline the entry of Saudi food and pharmaceutical exports into EU markets, fostering joint growth opportunities. Additionally, the discussions covered potential cooperation in biotechnology legislation, pharmaceutical availability, and AI applications, aiming to harmonize regulatory policies and exchange best practices with specialized European agencies.

Implications and Impact

This collaboration is expected to enhance the global competitiveness of Saudi food and pharmaceutical industries, opening new markets and fostering innovation. By aligning regulatory standards with the EU, Saudi Arabia can ensure greater consumer trust and facilitate smoother trade relations. The meeting also highlights Saudi Arabia’s proactive approach to leveraging AI and biotechnology for sustainable development and economic diversification.

Vision 2030 Alignment

The discussions align closely with Saudi Arabia’s Vision 2030 goals of economic diversification, technological advancement, and global integration. By strengthening ties with the EU in health and food safety, Saudi Arabia is positioning itself as a key player in the global market, driving innovation and ensuring the highest standards of quality and safety for its products.

20 Questions

Q1. Who attended the meeting between SFDA and the EU?

A1. The meeting was attended by SFDA CEO Dr. Hisham Aljadhey, EU Director-General for Health and Food Safety Sandra Gallina, and Saudi Ambassador to the EU Haifa Al-Jedea.

Q2. Where did the meeting take place?

A2. The meeting took place in Brussels, Belgium.

Q3. What was the primary focus of the meeting?

A3. The meeting focused on enhancing international cooperation in health and food safety, harmonizing regulatory policies, and facilitating trade between Saudi Arabia and the EU.

Q4. What sectors were discussed during the meeting?

A4. The discussions covered food safety, pharmaceuticals, biotechnology legislation, and AI applications.

Q5. How does this meeting benefit Saudi Arabia?

A5. The meeting enhances Saudi Arabia’s global competitiveness, opens new markets, and ensures higher standards of quality and safety for its products.

Q6. What role does the SFDA play in this collaboration?

A6. The SFDA is responsible for aligning Saudi Arabia’s regulatory frameworks with international standards and ensuring the safety and quality of food and pharmaceutical products.

Q7. How does this meeting align with Vision 2030?

A7. The meeting supports Vision 2030 by promoting economic diversification, technological advancement, and global integration.

Q8. What are the expected outcomes of this meeting?

A8. Expected outcomes include enhanced trade relations, harmonized regulatory standards, and increased innovation in food and pharmaceutical sectors.

Q9. What is the significance of harmonizing regulatory policies?

A9. Harmonizing regulatory policies ensures smoother trade relations, greater consumer trust, and higher product quality.

Q10. How does this collaboration impact Saudi-EU relations?

A10. The collaboration strengthens bilateral ties, fosters mutual growth, and enhances cooperation in health and food safety sectors.

Q11. What is the role of AI in this collaboration?

A11. AI applications are discussed to enhance regulatory processes, improve efficiency, and drive innovation in health and food safety.

Q12. How does this meeting contribute to Saudi Arabia’s global market position?

A12. The meeting positions Saudi Arabia as a leader in health and food safety, driving innovation and ensuring high product standards.

Q13. What are the key areas of cooperation discussed?

A13. Key areas include biotechnology legislation, pharmaceutical availability, AI applications, and harmonizing regulatory policies.

Q14. How does this collaboration benefit the EU?

A14. The collaboration benefits the EU by facilitating access to high-quality Saudi food and pharmaceutical products and fostering innovation.

Q15. What is the role of Saudi Ambassador Haifa Al-Jedea in this meeting?

A15. Ambassador Al-Jedea facilitated the discussions and supported the strengthening of Saudi-EU relations in health and food safety.

Q16. How does this meeting impact Saudi Arabia’s pharmaceutical industry?

A16. The meeting enhances the global competitiveness of Saudi Arabia’s pharmaceutical industry by aligning regulatory standards with the EU.

Q17. What is the importance of biotechnology legislation in this collaboration?

A17. Biotechnology legislation ensures the safe and effective use of biotech products, fostering innovation and regulatory harmonization.

Q18. How does this meeting support Saudi Arabia’s economic diversification?

A18. The meeting supports economic diversification by opening new markets and fostering innovation in food and pharmaceutical sectors.

Q19. What is the significance of facilitating Saudi exports to the EU?

A19. Facilitating exports enhances trade relations, boosts economic growth, and ensures greater market access for Saudi products.

Q20. How does this collaboration align with global health and safety standards?

A20. The collaboration aligns Saudi Arabia’s regulatory frameworks with global standards, ensuring the highest levels of health and safety for consumers.

---